In Vitro Profile of Hydrocortisone Release from Three-Dimensionally Printed Paediatric Mini-Tablets

Chrystalla Protopapa,Angeliki Siamidi,Siva Satyanarayana Kolipaka,Laura Andrade Junqueira,Dennis Douroumis,Marilena Vlachou

DOI: https://doi.org/10.3390/pharmaceutics16030385

IF: 6.525

2024-03-12

Pharmaceutics

Abstract:Three-dimensional (3D) printing is quickly being adopted in pharmaceutics due to the many advantages it offers, including treatment, adaptability, the reduction in waste and the accelerated development of new formulations. In this study, micro-extrusion printing was implemented for the production of modified-release hydrocortisone (HCT) mini-tablets for paediatric patients. For the developed formulations, Gelucire® 44/14 and Precirol® ATO 5 were used as the main inks at three different ratios: 70%/30%, 60%/40% and 50%/50%, respectively. The printing parameters (temperature and pressure) were altered accordingly for each ratio to achieve printability. The printed mini-tablets exhibited excellent printing quality, featuring consistent layer thicknesses and smooth surfaces. Dissolution tests were performed, and the results indicated a successful modified release of HCT from the mini-tablets. In summary, micro-extrusion exhibited favourable processing abilities for powder blends, facilitating quick printing and the fabrication of potential personalized dosages.

pharmacology & pharmacy

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to develop an innovative micro - extrusion 3D printing method for manufacturing hydrocortisone (HCT) sustained - release mini - tablets for children to achieve personalized drug administration. Specifically, the research aims to control drug release by adjusting tablet design while eliminating the need for pretreatment steps. In addition, this study also focuses on reducing the side effects that may accompany the traditional drug manufacturing process and improving the safety and effectiveness of drugs, especially for pediatric patients who require precise dose adjustment.

The paper mentions that the traditional drug manufacturing process is usually not flexible enough to be adjusted according to the individual needs of patients. However, 3D printing technology provides a high degree of adaptability. It can easily adjust the dose or combine multiple drugs in a single dosage form, simplify the production process, reduce waste, and can quickly prototype new drug formulations, significantly accelerating the development process. Therefore, this study utilizes 3D printing technology, especially micro - extrusion printing technology, to develop hydrocortisone - sustained - release mini - tablets suitable for children. It aims to reduce the frequency of drug administration, improve patient compliance, and personalize the dose according to the specific needs of each child, so as to reach the necessary treatment level while reducing the side effects caused by over - medication.

Through this method, researchers hope to provide a safer and more effective treatment option, especially in pediatric patients. These patients often need regular dose adjustments due to changes in age and weight, and are therefore more prone to drug - use errors. This study not only shows the potential of 3D printing technology in drug manufacturing, but also provides new ideas for future personalized medicine.